Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  SAR-407899

SAR-407899

Basic information Safety Supplier Related

SAR-407899 Basic information

Product Name:
SAR-407899
Synonyms:
  • SAR 407899
  • SAR407899
  • SAR-407899
  • 6-(piperidin-4-yloxy)isoquinolin-1(2H)-one hydrochloride
  • 6-(piperidin-4-yloxy)isoquinolin-1(2h)-one hcl
  • SAR407899 (hydrochloride)
  • SAR407899 HCl
  • 6-(4-Piperidinyloxy)-1(2H)-isoquinolinone hydrochloride
CAS:
923262-96-8
MF:
C14H17ClN2O2
MW:
280.74998
Product Categories:
  • API
Mol File:
923262-96-8.mol
More
Less

SAR-407899 Chemical Properties

storage temp. 
Store at -20°C
solubility 
H2O : 50 mg/mL (178.09 mM; Need ultrasonic)DMSO : 25 mg/mL (89.05 mM; Need ultrasonic)
form 
Powder
color 
Light yellow to khaki
More
Less

SAR-407899 Usage And Synthesis

Uses

SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.

in vivo

SAR407899 (3 mg/kg, i.v.) inhibits ROCK-mediated phosphorylation of MYPTT696 in thoracic aorta of spontaneously hypertensive rats (SHRs). SAR407899 (0.01-0.30 mg/kg, i.v.) efficiently reduces pressor responses to vasoconstrictor agents in rats. SAR407899 (1, 3, 10, and 30 mg/kg, p.o.) dose dependently lowers blood pressure in hypertensive SHRs[1]. SAR407899 (1-3 mg/kg, i.v. or 3, 10 mg/kg, p.o.) increases the length of the penis in healthy rabbits. SAR407899 (3-10 mg/kg, p.o.) also dose-dependently increases penile length in diabetic rabbits[2].

IC 50

ROCK-2: 102 nM (IC50); ROCK-1: 276 nM (IC50)

References

[1] L?hn M, et al. Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor. Hypertension. 2009 Sep;54(3):676-83. DOI:10.1161/HYPERTENSIONAHA.109.134353
[2] Guagnini F, et al. Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa. J Transl Med. 2012 Mar 23;10:59. DOI:10.1186/1479-5876-10-59
[3] Chen W, et al. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.Transpl Immunol. 2018 Jun 6. pii: S0966-3274(18)30029-7. DOI:10.1016/j.trim.2018.06.002

SAR-407899Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
CEG Chemical Science&Technology Co., Ltd.
Tel
Mobile:13665161512
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Email
info@adooq.cn